Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Revenue projections:

Revenue projections for SUVENPHAR
Revenue projections for SUVENPHAR

Suven Pharmaceuticals Limited's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.0
forwardPE 0.0
debtToEquity 0.0
earningsGrowth 0.0
revenueGrowth 0.0
grossMargins 0.0
operatingMargins 0.0
trailingEps 0.0
forwardEps 0.0


Price projections:

Price projections for SUVENPHAR
Price projections for SUVENPHAR

Suven Pharmaceuticals Limited's current valuation aligns with projections, revealing no significant risks or opportunities. This stable environment may lead investors to adopt a wait-and-see strategy, monitoring future developments closely.

Recommendation changes over time:

Recommendations trend for SUVENPHAR
Recommendations trend for SUVENPHAR


SUVENPHAR has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as SUVENPHAR is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.